Nature | Biotechnology Follow Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment Six proteomic clocks are applied in a clinical trial to assess anti-aging effects. https://www.nature.com/articles/s41587-026-03286-y nature.com
